Document is current

Any future updates will be listed below

Positive phase II trial of IL-17A–IL-17F-targeting nanobody sonelokimab for PsA

Crossref DOI link: https://doi.org/10.1038/s41584-025-01335-5

Published Online: 2025-11-26

Published Print: 2026-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark